Increased plasma DYRK1A with aging may protect against neurodegenerative diseases - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Translational Psychiatry Année : 2023

Increased plasma DYRK1A with aging may protect against neurodegenerative diseases

Résumé

Early markers are needed for more effective prevention of Alzheimer’s disease. We previously showed that individuals with Alzheimer’s disease have decreased plasma DYRK1A levels compared to controls. We assessed DYRK1A in the plasma of cognitively healthy elderly volunteers, individuals with either Alzheimer’s disease (AD), tauopathies or Down syndrome (DS), and in lymphoblastoids from individuals with DS. DYRK1A levels were inversely correlated with brain amyloid β burden in asymptomatic elderly individuals and AD patients. Low DYRK1A levels were also detected in patients with tauopathies. Individuals with DS had higher DYRK1A levels than controls, although levels were lower in individuals with DS and with dementia. These data suggest that plasma DYRK1A levels could be used for early detection of at risk individuals of AD and for early detection of AD. We hypothesize that lack of increase of DYRK1A at middle age (40–50 years) could be a warning before the cognitive decline, reflecting increased risk for AD.

Mots clés

Fichier principal
Vignette du fichier
s41398-023-02419-0.pdf (1.34 Mo) Télécharger le fichier
Origine : Publication financée par une institution
Licence : CC BY - Paternité

Dates et versions

hal-04505110 , version 1 (14-03-2024)

Identifiants

Citer

Jean M Delabar, Julien Lagarde, Marta Fructuoso, Ammara Mohammad, Michel Bottlaender, et al.. Increased plasma DYRK1A with aging may protect against neurodegenerative diseases. Translational Psychiatry, 2023, 13 (111), ⟨10.1038/s41398-023-02419-0⟩. ⟨hal-04505110⟩
5 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More